Abstract | BACKGROUND AND AIMS: METHODS: The study comprised 159 acute stroke patients and 51 age-matched controls. Plasma chitotriosidase activity was serially determined by fluorometric assay. Short-term neurological outcome was determined at 48 h and functional outcome at three-months. Predictors of neurological and functional outcome were determined via multivariate analysis, and the additional predictive value of chitotriosidase was tested with the Integrated Discrimination Index and the Net Reclassification Improvement. RESULTS:
Stroke patients showed increased levels of baseline chitotriosidase activity compared to controls [114·2 (74·65-182·95) nmol/ml/h vs. 54·4 (32·7-76·4); P < 0·0001]. Chitotriosidase activity (<118·75) was found to be an independent predictor of neurological improvement at 48 h (odds ratio: 3·25; 95% confidence interval: 1·54-6·85; P=0·002), and the addition of plasma chitotriosidase activity showed a better prediction of improvement at 48 h (Integrated Discrimination Index=5·7%, Net Reclassification Improvement=11·6%, P<0·05) over the predictive model constituted only with clinical information. Although patients disabled at three-months showed higher baseline chitotriosidase levels, it was not an independent predictor of long-term disability. CONCLUSIONS:
|
Authors | Alejandro Bustamante, Carmen Dominguez, Víctor Rodriguez-Sureda, Angel Vilches, Ana Penalba, Dolors Giralt, Teresa García-Berrocoso, Victor Llombart, Alan Flores, Marta Rubiera, Carlos Molina, José Alvarez-Sabín, Joan Montaner |
Journal | International journal of stroke : official journal of the International Stroke Society
(Int J Stroke)
Vol. 9
Issue 7
Pg. 910-6
(Oct 2014)
ISSN: 1747-4949 [Electronic] United States |
PMID | 24148838
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization. |
Chemical References |
- Biomarkers
- Hexosaminidases
- chitotriosidase
|
Topics |
- Aged
- Biomarkers
(blood)
- Female
- Hexosaminidases
(blood)
- Humans
- Male
- Multivariate Analysis
- Prognosis
- Stroke
(blood, diagnosis, therapy)
- Treatment Outcome
|